Source: International Congress 2016 – Orphan diseases II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elzbieta Radzikowska (Warsaw, Poland), Elzbieta Radzikowska, Elzbieta Wiatr, Dariusz Gawryluk, Renata Langfort, Iwona Bestry, Piotr Rudzinski, Ewa Szczepulska-Wójcik, Kazimierz Roszkowski-Sliz. Cryptogenic organizing pneumonia – Results of treatment with clarithromycin versus corticosteroids. Eur Respir J 2016; 48: Suppl. 60, 3907

Member's Comments

No comment yet.

Related content which might interest you: A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia Source: International Congress 2015 – New insights into IIPs Year: 2015 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Azithromycin therapy in children with postinfectious bronchiolitis obliterans Source: International Congress 2016 – Paediatric respiratory infection Year: 2016 Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia Source: International Congress 2014 – ILDs 4 Year: 2014 Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Eosinophilic pneumonia associated with pirfenidone therapy Source: Eur Respir J 2016; 48: 1240-1242 Year: 2016 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 COPD and pneumonia Source: International Congress 2015 – Different data in COPD Year: 2015 Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Idiopathic pulmonary fibrosis treatment: Combined pirfenidone + acetylcysteine vs N-acetylcysteine in monotherapy Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Desquamative interstitial pneumonia: Follow-up of 17 patients Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Lymphangioma in patients with pulmonary lymphangioleiomyomatosis – Results of sirolimus treatment Source: International Congress 2016 – Orphan diseases I Year: 2016